UC Davis Health Researchers Identify Biomarkers for Schizophrenia in 22q11.2 Deletion Syndrome

A 2008 report published in Current Psychiatry Reports found that approximately 1% of people with schizophrenia also have a rare genetic disorder called 22q11.2 deletion syndrome. This suggests that schizophrenia…

Continue Reading UC Davis Health Researchers Identify Biomarkers for Schizophrenia in 22q11.2 Deletion Syndrome
Doctors Identify Coding DNA Variants that Could Cause Childhood-Onset Schizophrenia
Found on Unsplash

Doctors Identify Coding DNA Variants that Could Cause Childhood-Onset Schizophrenia

Editor's Note: We believe that patients are a key part of developing and leading the conversation in disease communities. Patient Worthy sometimes partners with reputable agencies that wish to speak…

Continue Reading Doctors Identify Coding DNA Variants that Could Cause Childhood-Onset Schizophrenia
C4 Genes as a Double-Edged Sword: Sex-Based Differences in Lupus, Schizophrenia, and Sjögren’s Syndrome
source: pixabay.com

C4 Genes as a Double-Edged Sword: Sex-Based Differences in Lupus, Schizophrenia, and Sjögren’s Syndrome

  Women can do anything that men can do, and vice versa. Well, while that sentiment may be true in our everyday life, it isn't quite true on a genetic…

Continue Reading C4 Genes as a Double-Edged Sword: Sex-Based Differences in Lupus, Schizophrenia, and Sjögren’s Syndrome
New Digital Therapies Developed For Schizophrenia and Multiple Sclerosis Patients
Source: Pixabay

New Digital Therapies Developed For Schizophrenia and Multiple Sclerosis Patients

Novartis and Pear Therapeutics have joined forces to develop digital therapeutic software applications to treat patients with schizophrenia and multiple sclerosis, reports World Pharma News. Novartis is known for the…

Continue Reading New Digital Therapies Developed For Schizophrenia and Multiple Sclerosis Patients